Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 606

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 606
---
 the surviving company upon completion of its initial business combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one -tenth(1/10) of a share underlying each right upon consummation of the business combination. No additional consideration will be required to be paid by a holder of rights in order to receive his, her or its additional shares of common stock upon consummation of an initial business combination. The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company). If the Company enters into a definitive agreement for a business combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the common stock will receive in the transaction on an as -convertedinto common stock basis. F-46

BELLEVUE LIFE SCIENCES ACQUISITION CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023

NOTE 8 — FAIR VALUE MEASUREMENTS

|                                   |     |   | December 31, 
         2023 |     |   |     Quoted 
  Prices In 
     Active 
    Markets 
  (Level 1) |     |   | Significant 
 Other       
 Observable  
 Inputs      
 (Level 2)   |     |   | Significant  
 Other        
 Unobservable 
 Inputs       
 (Level 3)    |
|:----------------------------------|:----|:--|-------------:|:----|:--|-----------:|:----|:--|:------------|:----|:--|:-------------|
| Assets:                           |     |   |              |     |   |            |     |   |             |     |   |              |
| Investments held in Trust Account |     | $ |   36,605,106 |     | $ | 36,605,106 |     | $ | —           |     | $ | —            |

There were no transfers between Levels1, 2 and 3 during the year ended December31, 2023.

NOTE 9 — SUBSEQUENT EVENTS The Company evaluated subsequent events to determine if events or transactions occurred after the balance sheet date up to the date the financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements, other than the following: •On